CND Life Sciences

HealthcareSeries AScottsdale, UScndlifesciences.com

Latest round

Series A

Last raised

May 2025

Total raised

$22M

Investors

14

About CND Life Sciences

, formerly known as Cutaneous NeuroDiagnostics, LLC, operates a laboratory that produces alternative aid for neurodegenerative diseases and other conditions. In August 2026, CND Life Sciences, Inc. The firm’s primary offering is the Syn-One Test®, which detects, visualizes and quantifies misfolded phosphorylated alpha-synuclein in skin nerve fibers. The test aids in diagnosing synucleinopathies, including Parkinson’s disease, dementia with Lewy bodies, multiple system atrophy, and pure autonomic failure. The test involves analyzing skin biopsies for accurate and minimally invasive diagnosis. CND Life Sciences also engages in research collaborations to diagnostic capabilities and explore biomarkers for neurodegenerative diseases.

Who invested in CND Life Sciences

14 investors across 3 rounds

See all investors in CND Life Sciences

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    May 20, 2025

    Amount

    $14M

    Investors

    Locked

  2. Series A

    May 6, 2025

    Amount

    $5.1M

    Investors

    Locked

  3. Series A

    Feb 28, 2025

    Amount

    $3.5M

    Investors

    Locked

Questions about CND Life Sciences

Who invested in CND Life Sciences?

CND Life Sciences has 14 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has CND Life Sciences raised?

CND Life Sciences has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did CND Life Sciences last raise money?

CND Life Sciences's most recent round on record is a Series A, in May 2025.

What does CND Life Sciences do?

, formerly known as Cutaneous NeuroDiagnostics, LLC, operates a laboratory that produces alternative aid for neurodegenerative diseases and other conditions.

Where is CND Life Sciences headquartered?

CND Life Sciences is headquartered in Scottsdale, US.

Which VCs invest in companies like CND Life Sciences?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Kleiner Perkins and Lightspeed Venture Partners back healthcare companies at CND Life Sciences's stage. Their profiles are linked below.

Raising like CND Life Sciences? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.